Nisa Investment Advisors
TYRA icon

Nisa Investment Advisors’s Tyra Biosciences TYRA Stock Holding History

Nisa Investment Advisors’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.37K Buy
88
+2
+2% +$65 ﹤0.01% 2533
2025
Q4 		$2.26K Hold
86
– – ﹤0.01% 2589
2025
Q3 		$1.2K Hold
86
– – ﹤0.01% 2713
2025
Q2 		$823 Sell
86
-63
-42% -$599 ﹤0.01% 2773
2025
Q1 		$1.39K Buy
149
+126
+548% +$1.63K ﹤0.01% 2553
2024
Q4 		$320 Sell
23
-17
-43% -$309 ﹤0.01% 2888
2024
Q3 		$940 Hold
40
– – ﹤0.01% 2594
2024
Q2 		$640 Buy
40
+6
+18% +$103 ﹤0.01% 2629
2024
Q1 		$558 Buy
34
+18
+113% +$295 ﹤0.01% 2482
2023
Q4 		$222 Hold
16
– – ﹤0.01% 2537
2023
Q3 		$220 Hold
16
– – ﹤0.01% 2652
2023
Q2 		$272 Hold
16
– – ﹤0.01% 2671
2023
Q1 		$0 Hold
16
– – ﹤0.01% 2714
2022
Q4 		$0 Buy
+16
New +$113 ﹤0.01% 2732

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Nisa Investment Advisors's TYRA Position: Q1 2026 in Review

Nisa Investment Advisors increased its Tyra Biosciences (TYRA) stake by 2.3% in Q1 2026, buying an estimated $65 and bringing the position to 88 shares worth $3.37K. The position accounts for ﹤0.01% of the portfolio, ranked #2533.

Nisa Investment Advisors first reported a position in TYRA in Q4 2022 and has held it in 14 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Nisa Investment Advisors held 88 shares of Tyra Biosciences worth $3.37K as of Q1 2026.
  • Nisa Investment Advisors bought 2 Tyra Biosciences shares in Q1 2026, an estimated $65.
  • Tyra Biosciences made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2533 holding.
  • Nisa Investment Advisors first reported a position in Tyra Biosciences in Q4 2022 and has held it in 14 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.